“…T 2 -weighted imaging (T 2 WI), in which tumour tissue appears hypointense relative to the normal peripheral tissue, 2 has been used for morphological prostate tumour detection and localization, but the specificity of T 2 WI is low because benign prostatic hyperplasia, prostatitis, fibrosis and postbiopsy haemorrhage also cause T 2 hypointensities. [3][4][5] In addition, some prostate tumours appear normal on T 2 WI, leading to low sensitivity of this method. 6,7 Functional MR techniques (such as dynamic contrast-enhanced MRI [DCE-MRI], diffusion-weighted imaging [DWI], and magnetic resonance spectroscopy [MRS]) have been used to increase the diagnostic accuracy of MR in prostate cancer.…”